Neutralization against emerging Omicron subvariants after SARS-CoV-2 reinfection - 23/11/23
Doi : 10.1016/j.jinf.2023.09.013
Shen Tian 1
State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, PR China
Institute of Public Health, Guangzhou Medical University, Guangzhou, PR China
Guangzhou Center for Disease Control and Prevention, Guangzhou, PR China
Xin-Jing Zhao 3
State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, PR China
Department of Epidemiology and Health Statistics, School of Public Health, Anhui Medical University, Hefei, PR China
Xin-Lou Li
Department of Medical Research, Key Laboratory of Environmental Sense Organ Stress and Health of the Ministry of Ecology and Environment, PLA Strategic Support Force Medical Center, Beijing, PR China
Li-Qun Fang ⁎ 
State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, PR China
Department of Epidemiology and Health Statistics, School of Public Health, Anhui Medical University, Hefei, PR China
*Corresponding author at: State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, PR China.State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and EpidemiologyBeijingPR China
∗Corresponding author.
Yue-Hong Wei ⁎
Institute of Public Health, Guangzhou Medical University, Guangzhou, PR China
Guangzhou Center for Disease Control and Prevention, Guangzhou, PR China
∗Corresponding author at: Institute of Public Health, Guangzhou Medical University, Guangzhou, PR China.Institute of Public Health, Guangzhou Medical UniversityGuangzhouPR China
Guo-Lin Wang ⁎
State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, PR China
∗Corresponding author.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Highlights |
• | XBB subvariants escape the immunity induced by primary infection or reinfection. |
• | SARS-CoV-2 reinfection can alleviate WT-vaccination-induced immune imprinting. |
• | G339H, G446S, N460K, and F486S/P mutations are essential for immune escape. |
Plan
© 2023
The British Infection Association. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 87 - N° 6
P. 598-601 - décembre 2023 Retour au numéro
Article précédent
- Defining infection transmission pathways for future pandemic preparedness – An urgent public health research priority
- Daniel Pan, David S.C. Hui, Julian W. Tang
- Prevalence of Hepatitis B virus infection in patients attending Cardiac super-specialty hospital between 2014 and 2022
- Naveena J, Kavitha K, Nandini M P, Manjunath C N, Prapulla Kumari N, Praveen Kumar H D
Bienvenue sur EM-consulte, la référence des professionnels de santé.